CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
The atopic dermatitis market is facing increased growth, with a projected market...
A study suggests that children may face a higher risk of harm if their father is...
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD...
NImmune Biopharma and BioTherapeutics have partnered to develop new precision me...
German life science company Evotec has announced a collaboration with X-Chem to ...
The US FDA has approved Amneal Pharmaceuticals and Shilpa Medicare’s oncology pr...
Biogen plans to apply for regulatory approval of this investigational dose regim...
The company had focused its resources on Filspari’s launch in IgAN after the US ...
NHS England has announced the availability of MSD UK’s belzutifan, a take-at-hom...